Lawrence W. Myers

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1995 · 1.9K citations

A health-related quality of life measure for multiple sclerosis

Barbara G. Vickrey, Ron D. Hays, R. Harooni et al. · Quality of Life Research · 1995 · 1.1K citations

Reliability, Quality Of Life, Life Assessment +2

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1998 · 511 citations

Glatiramer Acetate Treatment, Rheumatology, Clinical Therapeutic +13

Criteria for the clinical diagnosis of multiple sclerosis

Augustus S. Rose, George W. Ellison, Lawrence W. Myers et al. · Neurology · 1976 · 371 citations

Neurological Disorder, Medicine, Diagnostic Criterion +6

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

K. P. Johnson, Benjamin Brooks, Corey C. Ford et al. · Multiple Sclerosis Journal · 2000 · 227 citations